2026 Myocardial Infarction Management Guidelines
The most current comprehensive guidelines for acute myocardial infarction management are the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guidelines for Acute Coronary Syndromes, which supersede previous recommendations and provide evidence-based protocols for STEMI and NSTEMI management. 1, 2
Initial Diagnosis and ECG Acquisition
- Obtain and interpret a 12-lead ECG within 10 minutes of first medical contact in all patients with suspected ACS 3, 2
- Prehospital 12-lead ECGs by trained EMS personnel reduce reperfusion times and mortality when integrated into care pathways 2
- ECG monitoring with defibrillator capacity must be initiated immediately in all suspected STEMI patients 3
- Look for STEMI equivalents beyond classic ST-elevation: bundle branch block, ventricular pacing, hyperacute T-waves, isolated ST-depression in anterior leads (suggesting posterior MI), or diffuse ST-depression with ST-elevation in aVR 3
Reperfusion Strategy Selection
Primary PCI is the preferred reperfusion strategy unless the anticipated time from STEMI diagnosis to PCI-mediated reperfusion exceeds 120 minutes, in which case fibrinolysis should be initiated within 10 minutes of diagnosis. 3
Primary PCI Pathway:
- Transfer patients directly to the catheterization laboratory, bypassing the emergency department 3
- EMS should alert the PCI center immediately after STEMI diagnosis 3
- PCI-capable centers must provide 24/7 service without delay 3
- Routine radial access and drug-eluting stent (DES) implantation are standard of care 3
- Routine thrombus aspiration and deferred stenting are contraindicated 3
Fibrinolysis Pathway (when PCI >120 minutes):
- Initiate fibrinolysis within 10 minutes of STEMI diagnosis, preferably pre-hospital 3
- Use fibrin-specific agents: tenecteplase, alteplase, or reteplase 3
- All patients require transfer to PCI-capable center immediately after fibrinolysis 3
- Perform angiography and PCI of infarct-related artery between 2-24 hours after successful fibrinolysis 3
- Rescue PCI is indicated immediately if fibrinolysis fails (<50% ST-segment resolution at 60-90 minutes) or with hemodynamic/electrical instability 3
Antithrombotic Therapy
For Primary PCI:
- Aspirin (oral or IV) loading dose immediately 3
- Potent P2Y12 inhibitor: prasugrel or ticagrelor preferred over clopidogrel, given before or at time of PCI 3
- Unfractionated heparin (enoxaparin or bivalirudin are alternatives) 3
- Fondaparinux is contraindicated for primary PCI 3
For Fibrinolysis:
- Aspirin (oral or IV) 3
- Clopidogrel in addition to aspirin 3
- Enoxaparin IV followed by subcutaneous (preferred over unfractionated heparin) 3
- Continue anticoagulation until revascularization or up to 8 days of hospital stay 3
Maintenance Therapy:
- Dual antiplatelet therapy (DAPT) for 12 months: aspirin plus ticagrelor or prasugrel (clopidogrel if others unavailable/contraindicated) 3
- Low-dose aspirin (75-100 mg) long-term 3
Cardiac Biomarkers
- Measure cardiac troponin as soon as possible, preferably using high-sensitivity troponin (hs-cTn) assay 2
- Repeat troponin measurement if initial value is non-diagnostic in patients with ongoing suspicion 2
Special Populations and Situations
Post-Cardiac Arrest:
- Primary PCI strategy for patients with ST-elevation on post-resuscitation ECG 3
- Without ST-elevation but high suspicion of ischemia: urgent angiography within 2 hours after excluding non-coronary causes 3
- Targeted temperature management for unresponsive patients after resuscitation 3
- Do not use pre-hospital cooling with rapid infusion of large volumes of cold IV fluid 3
Non-Infarct Related Artery (Non-IRA) Lesions:
- Treat severe stenosis (by angiography or FFR) before hospital discharge (during index PCI or staged) 3
- In cardiogenic shock, consider non-IRA PCI during index procedure 3
High-Risk Subgroups Requiring Dose Adjustments:
Oxygen and Symptom Management
- Routine oxygen is NOT recommended in patients with oxygen saturation ≥90% 3
Post-Reperfusion Care
- Monitor patients for at least 24 hours after reperfusion therapy 3
- Routine echocardiography during hospital stay to assess LV/RV function, detect mechanical complications, and exclude LV thrombus 3
- Early ambulation and discharge for uncomplicated patients 3
Long-Term Medical Therapy
Mandatory Medications:
- High-intensity statin therapy started as early as possible, with LDL-C goal <1.8 mmol/L (70 mg/dL) or ≥50% reduction 3
- ACE inhibitors within first 24 hours for patients with heart failure, LV dysfunction, diabetes, or anterior infarct 3
- Beta-blockers for patients with heart failure and/or LVEF <40% 3
- Avoid IV beta-blockers in patients with hypotension, acute heart failure, AV block, or severe bradycardia 3
- Mineralocorticoid receptor antagonists (MRAs) for patients with ejection fraction <40% and heart failure or diabetes 3
- Proton pump inhibitor (PPI) with DAPT for patients at high gastrointestinal bleeding risk 3
Secondary Prevention
- Identify all smokers and provide intensive cessation support with nicotine replacement, varenicline, or bupropion 3
- Cardiac rehabilitation program participation is mandatory 3
Critical Pitfalls to Avoid
- Do not delay reperfusion for routine thrombus aspiration 3
- Do not perform routine PCI of occluded infarct-related artery >48 hours after STEMI onset in asymptomatic patients 3
- Do not use fondaparinux for primary PCI 3
- Do not give IV beta-blockers to hemodynamically unstable patients 3
- Do not allow emergency department delays—transfer STEMI patients directly to catheterization laboratory 3